Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Stevenson

Showing results (291-300 of 950) with videos related to

Pageof 95
Sort By:
Metabolism: Clinical and Experimental|April 1, 1994
Insulin propeptides in conditions associated with insulin resistance in humans and their relevance to insulin measurementsA J Proudler, I F Godsland, J C Stevenson
Calcified Tissue International|December 1, 1984
Racial differences in calcitonin and katacalcinJ C Stevenson, C H Myers, A B Ajdukiewicz
Journal of the Royal Society of Medicine|June 1, 1991
Hormone replacement therapyM C Ellerington, M I Whitehead, J C Stevenson
Transplantation|February 1, 1992
Recurrent variceal bleeding after liver transplantation--persistent left-sided portal hypertensionW C Stevenson, R G Sawyer, T L Pruett
British Journal of Obstetrics and Gynaecology|April 1, 1993
Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosisM S Marsh, J C Stevenson, M I Whitehead
Immunology Series|January 1, 1989
Activated killer monocytes: use in clinical trialsL V Lacerna, P H Sugarbaker, H C Stevenson
American Journal of Physical Anthropology|July 1, 1985
Immunoglobulin allotypes in Jewish populations living in Israel and the United StatesJ C Stevenson, M S Schanfield, S G Sandler
Child Maltreatment|March 28, 2024
Effects of COVID on Mandated Child Abuse Reporting Among Nurses: The Mediating Role of Compassion FatigueMargaret C Stevenson, Vaishnavi M Ravipati, Cynthia T Schaefer
Maturitas|August 7, 2010
Oral ultra-low dose continuous combined hormone replacement therapy with 0.5 mg 17β-oestradiol and 2.5 mg dydrogesterone for the treatment of vasomotor symptoms: results from a double-blind, controlled studyJohn C Stevenson, Gemma Durand, Elke Kahler, et al.
Artificial Organs|April 1, 1988
The treatment of cancer with activated cytotoxic leukocyte subsetsH C Stevenson, G W Stevenson, L V Lacerna
Pageof 95

Showing results (291-300 of 950) with videos related to

Sort By:
Pageof 95
Metabolism: Clinical and Experimental|April 1, 1994
Insulin propeptides in conditions associated with insulin resistance in humans and their relevance to insulin measurementsA J Proudler, I F Godsland, J C Stevenson
Calcified Tissue International|December 1, 1984
Racial differences in calcitonin and katacalcinJ C Stevenson, C H Myers, A B Ajdukiewicz
Journal of the Royal Society of Medicine|June 1, 1991
Hormone replacement therapyM C Ellerington, M I Whitehead, J C Stevenson
Transplantation|February 1, 1992
Recurrent variceal bleeding after liver transplantation--persistent left-sided portal hypertensionW C Stevenson, R G Sawyer, T L Pruett
British Journal of Obstetrics and Gynaecology|April 1, 1993
Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosisM S Marsh, J C Stevenson, M I Whitehead
Immunology Series|January 1, 1989
Activated killer monocytes: use in clinical trialsL V Lacerna, P H Sugarbaker, H C Stevenson
American Journal of Physical Anthropology|July 1, 1985
Immunoglobulin allotypes in Jewish populations living in Israel and the United StatesJ C Stevenson, M S Schanfield, S G Sandler
Child Maltreatment|March 28, 2024
Effects of COVID on Mandated Child Abuse Reporting Among Nurses: The Mediating Role of Compassion FatigueMargaret C Stevenson, Vaishnavi M Ravipati, Cynthia T Schaefer
Maturitas|August 7, 2010
Oral ultra-low dose continuous combined hormone replacement therapy with 0.5 mg 17β-oestradiol and 2.5 mg dydrogesterone for the treatment of vasomotor symptoms: results from a double-blind, controlled studyJohn C Stevenson, Gemma Durand, Elke Kahler, et al.
Artificial Organs|April 1, 1988
The treatment of cancer with activated cytotoxic leukocyte subsetsH C Stevenson, G W Stevenson, L V Lacerna
Pageof 95